Gross Margin Expansion of 79 Basis Points
Adjusted EPS Growth of Nearly Four Times with GAAP EPS Loss of $ and Adjusted EPS of $0.19
Investments Outlined at 2023 Investor Day for Long-Term Growth.
Owens & Minor impresses with Q1 results: adjusted EPS of $0.19, and sales of $2.61B (up 4% Y/Y). Patient Direct revenue reaches $638M (up 5% Y/Y). CEO Edward Pesicka highlights growth strategies and reaffirms 2024 revenue guidance of $10.5-$10.9 billion and adjusted EPS of $1.40-$1.70.
The Power 50 - Virginia Business virginiabusiness.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from virginiabusiness.com Daily Mail and Mail on Sunday newspapers.